Clinical trial: Prenatal DHA prevents blood-pressure increase from obesity during childhood
Article

Clinical trial: Prenatal DHA prevents blood-pressure increase from obesity during childhood

Public health
4 min read

Research published today in JAMA Network Open by investigators at the University of Kansas and KU Medical Center finds pregnant mothers who daily consumed 600 milligrams of docosahexaenoic acid (DHA) -- an omega-3 fatty acid found in prenatal vitamins, fish-oil supplements and fish meat -- protected their offspring from the blood pressure-elevating effects of excessive weight in early childhood.

Reference

Kerling EH, Hilton JM, Thodosoff JM, Wick J, Colombo J, Carlson SE. Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2019;2(2):e190088 - Link

Links: https://www.eurekalert.org/pub_releases/2019-02/uok-ctp021919.php

This content is for registered users only.
Registration is free and reserved for healthcare professionals.

If you liked this post you may also like

Please log in to your profile so we can show recommended content.